Literature DB >> 10464024

Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2.

A J Lunato1, J Wang, J E Woollard, A K Anisuzzaman, W Ji, F G Rong, S Ikeda, A H Soloway, S Eriksson, D H Ives, T E Blue, W Tjarks.   

Abstract

Derivatives of thymidine containing o-carboranylalkyl groups at the N-3 position and derivatives of 2'-deoxyuridine containing o-carboranylalkylmercapto groups at the C-5 position were synthesized. The alkyl spacers consist of 4-8 methylene units. The synthesis of the former compounds required 3-4 reaction steps in up to 75% overall yield and that of the latter 9-10 reaction steps with significantly lower overall yield. Derivatives of thymidine substituted with carboranylalkyl substituents at the N-3 position and short spacers were phosphorylated by both recombinant and purified cytosolic thymidine kinase (TK1) to a relatively high degree. None of the tested 2'-deoxyuridine derivatives possessing carboranyl substituents at the C-5 position were phosphorylated by either recombinant or purified TK1. The amounts of phosphorylation product detected for some of the C-5-substituted nucleosides with recombinant mitochondrial thymidine kinase (TK2) were low but significant and decreased with increasing lengths of the alkyl spacer. The data obtained in this study do not seem to support the tether concept applied in the synthesis of the new C-5- and N-3-substituted carboranyl nucleosides intended to reduce possible steric interference in the binding of carboranyl nucleosides with deoxynucleoside kinases. Instead, it appeared that a closer proximity of the bulky carborane moiety to the nucleoside scaffold resulted in better substrate characteristics.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464024     DOI: 10.1021/jm990125i

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  7 in total

1.  A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine.

Authors:  Ning Guo; Jingping Xie; H Charles Manning; Natasha G Deane; M Sib Ansari; Robert J Coffey; John Gore; Ronald R Price; Ronald M Baldwin; J Oliver McIntyre
Journal:  Mol Imaging Biol       Date:  2011-04       Impact factor: 3.488

2.  Synthesis, biological evaluation, and radioiodination of halogenated closo-carboranylthymidine analogues.

Authors:  Rohit Tiwari; Antonio Toppino; Hitesh K Agarwal; Tianyao Huo; Youngjoo Byun; Judith Gallucci; Sherifa Hasabelnaby; Ahmed Khalil; Ayman Goudah; Robert A Baiocchi; Michael V Darby; Rolf F Barth; Werner Tjarks
Journal:  Inorg Chem       Date:  2011-12-16       Impact factor: 5.165

3.  The boron-neutron capture agent beta-D-5-o-carboranyl-2'-deoxyuridine accumulates preferentially in dividing brain tumor cells.

Authors:  Casey Moore; Brenda I Hernández-Santiago; Selwyn J Hurwitz; Chalet Tan; Chris Wang; Raymond F Schinazi
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

4.  Cellular influx, efflux, and anabolism of 3-carboranyl thymidine analogs: potential boron delivery agents for neutron capture therapy.

Authors:  Elena Sjuvarsson; Vijaya L Damaraju; Delores Mowles; Michael B Sawyer; Rohit Tiwari; Hitesh K Agarwal; Ahmed Khalil; Sherifa Hasabelnaby; Ayman Goudah; Robin J Nakkula; Rolf F Barth; Carol E Cass; Staffan Eriksson; Werner Tjarks
Journal:  J Pharmacol Exp Ther       Date:  2013-09-04       Impact factor: 4.030

Review 5.  N3-substituted thymidine bioconjugates for cancer therapy and imaging.

Authors:  Ahmed Khalil; Keisuke Ishita; Tehane Ali; Werner Tjarks
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

6.  Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.

Authors:  Hitesh K Agarwal; Craig A McElroy; Elena Sjuvarsson; Staffan Eriksson; Michael V Darby; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2012-12-05       Impact factor: 6.514

7.  Synthesis, chemical and enzymatic hydrolysis, and aqueous solubility of amino acid ester prodrugs of 3-carboranyl thymidine analogs for boron neutron capture therapy of brain tumors.

Authors:  Sherifa Hasabelnaby; Ayman Goudah; Hitesh K Agarwal; Mosaad S M abd Alla; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2012-07-27       Impact factor: 6.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.